This study proofs that Trp53–/– lymphomas lacking PCNAK164-facilitated DDT not only are highly sensitive to low dose chemotherapy, but also that in vivo CsPt treatment can cure 25% of mice suffering from a DDTD lymphoma. Here, TP53 is linked to lymphoma.